Streetbeat News

Partnerships

RDY

Dr. Reddy's Laboratories has agreed to make several payments to Coya Therapeutics, including a $7.5M upfront payment, $4.2M upon IND application acceptance, another $4.2M upon first patient dosing in a Phase 2 trial, and up to $40M in development and regulatory milestones. Additionally, Coya is eligible for up to $677.25M in sales-based milestones.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 12:24 pm

F

KSS

LEG

Wall Street's most accurate analysts recommend holding three high-dividend yield consumer stocks: Kohl's Corporation (KSS), Leggett & Platt (LEG), and Ford Motor Company (F). KSS has a dividend yield of 8.53%, with mixed analyst ratings and a recent report of worse-than-expected Q3 sales. LEG offers a 7.48% yield, with analysts maintaining Hold ratings and reducing price targets following downbeat Q3 earnings. Ford, with a 5.66% yield, has seen a mix of rating changes and price target adjustments, but recently announced a significant EV charging port deployment initiative.

Portfolio Pulse from Lisa Levin

December 06, 2023 | 12:17 pm

CSIQ

Canadian Solar Inc. announced that its majority-owned subsidiary e-STORAGE will deliver 226 MWh of turnkey energy storage solutions to ENGIE in the UK, specifically in Scotland.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 12:12 pm

RDY

Dr. Reddy's Laboratories has agreed to make a series of payments to Coya Therapeutics, including a $7.5M upfront payment, $4.2M upon IND application acceptance, $4.2M upon first patient dosing, and up to $40M in development and regulatory milestones. Additionally, Coya is eligible for up to $677.25M in sales-based milestones.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 12:09 pm

COYA

RDY

Coya Therapeutics and Dr. Reddy's Laboratories have entered into an exclusive collaboration for the development and commercialization of COYA 302, a treatment for ALS. Dr. Reddy's will gain commercialization rights for COYA 302 in the US, Canada, UK, and EU.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 12:05 pm

KMDA

Kamada Ltd. has announced a binding Memorandum of Understanding (MOU) with Kedrion Biopharma for amending and extending their US distribution agreement for KEDRAB, a rabies immune globulin. Under the new terms, Kedrion commits to purchasing minimum quantities of KEDRAB, ensuring revenues of $180 million to Kamada over the first four years.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 12:03 pm

NBY

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) has partnered with Woo University to offer a free educational webinar for eyecare professionals on the use of amniotic membranes. The webinar is scheduled for December 7, 2023. This initiative follows the commercial launch of NovaBay's Avenova Allograft in September 2023, a prescription amniotic membrane product for ocular surface repair.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 11:59 am

BIDU

NVDA

NVIDIA Corp. CEO Jensen Huang has recognized Huawei Technologies as a significant competitor in the AI chip market. During his visit to Singapore, he acknowledged the competition from Huawei, Intel, and various startups. Huawei has impressed the industry with a sophisticated smartphone processor and is a key player in China's independent chip environment. NVIDIA plans to launch new products for the Chinese market, complying with U.S. regulations. Baidu Inc. has switched from NVIDIA to Huawei for AI chips, highlighting shifts in global tech partnerships due to U.S. tech export restrictions.

Portfolio Pulse from Benzinga Neuro

December 06, 2023 | 11:40 am

IVP

Inspire Veterinary Partners entered into a Common Stock Purchase Agreement with Tumim Stone Capital on November 30. Tumim Stone Capital has committed to purchasing up to $30 million of Inspire Veterinary Partners' Class A Common Stock, as disclosed in an 8-K filing.

Portfolio Pulse from Charles Gross

December 06, 2023 | 11:11 am

VLKAF

XPEV

XPENG and Volkswagen are advancing in their collaboration to develop two B-Class Battery Electric Vehicle (BEV) models, as reported in a recent filing.

Portfolio Pulse from Charles Gross

December 06, 2023 | 10:54 am